Shareholders' Equity, Stock Plans and Preferred Stock (Tables)

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The table below shows the weighted average assumptions the Company used to develop the fair value estimates under its option valuation model:

	Year Ended December 31,
	2020	2019
Expected volatility (range)	N/A(1)	N/A(1)
Risk free interest rate (range)	N/A(1)	N/A(1)
Expected dividends	N/A(1)	N/A(1)
Weighted average expected term (years)	N/A(1)	N/A(1)

___________

(1)The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the years ended December 31, 2020 and 2019. All equity grants during

these periods were restricted common shares which are valued using an intrinsic valuation method based on market price.

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The table below describes the resulting weighted average grant date fair values calculated as well as the intrinsic value of options exercised under the Company's equity awards during each of the following years:

	Year Ended December 31,
	2020(1)		2019(1)
Weighted average grant date fair value	$	—	$	—
Total intrinsic value of exercises	$	—	$	3

___________

(1)The Company did not issue any options or other equity grants that would require application of the Black-Scholes-Merton equity grant valuation model during the years ended December 31, 2020 and 2019. All equity grants during this period were restricted common shares which are valued using an intrinsic valuation method based on market price.

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

The following table summarizes information regarding stock options and SOSAR grants outstanding as of December 31, 2020:

		Weighted
		Average			Intrinsic			Intrinsic
Range of		Exercise		Grants	Value-Grants		Grants	Value-Grants
Exercise Prices1		Prices		Outstanding	Outstanding		Exercisable	Exercisable
$8.14 to $10.21		$	8.83	45	$	—	45	$	—
$	5.86	$	5.86	20	$	—	20	$	—
				65			65

Schedule of Share-based Compensation Arrangements by Share-based Payment Award

Summarized activity of the equity compensation plans is presented below:

		Weighted
	SOSARs/	Average
	Options	Exercise Price
Outstanding, December 31, 2019	76	$	7.55
Granted	—	—
Exercised	—	—
Expired or cancelled	(11)	5.45
Outstanding, December 31, 2020	65	$	7.92
Exercisable, December 31, 2020	65	$	7.92

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

		Weighted
		Average
	Restricted	Grant Date
	Shares	Fair Value
Outstanding, December 31, 2019	207	$	5.28
Granted	198	2.00
Dividend Equivalents	—	—
Vested	(187)	3.93
Cancelled	(25)	4.55
Outstanding, December 31, 2020	193	$	3.32

Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:

		Weighted
		Average
	Restricted	Grant Date
	Share Units	Fair Value
Outstanding, December 31, 2019	48	$	5.08
Granted	28	2.00
Dividend Equivalents	—	—
Vested	(21)	6.45
Cancelled	—	—
Outstanding December 31, 2020	55	$	2.92